Best Biotechnology Product
The Prix Galien India Award for the Best Biotechnology Product is open to any biologic medicine (for example – vaccines, ATMPs, recombinant proteins, monoclonal antibodies) that has had a significant, positive impact on improving patient lives.
Products must have received marketing approval in the India by
December 31, 2023, but not more than ﬁve years earlier than December
31 of that year (unless the award is for a new/ innovative indication
added within the past ﬁve years).
We accept nominations for individual products, not classes of products. We assume that nominees possess permission of the current owner(s) of the product rights.
- See the Quick Facts Sheet
Combine the best science with the most efficient drug development plan